---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-034997"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2025-11-14T23:59:59+00:00"
generated_at: "2026-05-16T19:39:06.028825+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BIO-key Q3 revenue falls 28% to $1.55M; net loss widens; raises $3.1M via warrant exercise

## Summary
- Q3 2025 revenue $1.55M (down 28% YoY); net loss ($964,849) or ($0.15) per share vs ($738,959) ($0.39) in Q3'24.
- Full year 2025 revenue guidance $6.5-$7M.
- On Oct 27, raised $3.1M gross via warrant exercise at $1.02/share (3.09M shares); used proceeds to prepay notes.
- Launched EcoID III scanner; secured Middle East defense biometric deployment.
- Balance sheet: $2.0M cash at Sep 30 vs $0.4M at Dec 31; total notes outstanding $675k.

## SEC filing metadata
- accession: 0001437749-25-034997
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2025-11-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774925034997/0001437749-25-034997-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774925034997/bkyi20251113_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-034997
- JSON: https://secwatch.observer/filing/0001437749-25-034997.json
- Plain text: https://secwatch.observer/filing/0001437749-25-034997.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.